Cargando…
Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
Cardiovascular complications remain the leading cause of morbidity and mortality in individuals with diabetes, driven by interlinked metabolic, inflammatory, and thrombotic changes. Hyperglycaemia, insulin resistance/deficiency, dyslipidaemia, and associated oxidative stress have been linked to abno...
Autores principales: | Sagar, Rebecca C., Ajjan, Ramzi A., Naseem, Khalid M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9104718/ https://www.ncbi.nlm.nih.gov/pubmed/35563363 http://dx.doi.org/10.3390/ijms23094973 |
Ejemplares similares
-
PAI-1 in Diabetes: Pathophysiology and Role as a Therapeutic Target
por: Altalhi, Rawan, et al.
Publicado: (2021) -
Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022) -
Thrombosis and Vascular Inflammation in Diabetes: Mechanisms and Potential Therapeutic Targets
por: Pechlivani, Nikoletta, et al.
Publicado: (2018) -
Hypofibrinolysis in diabetes: a therapeutic target for the reduction of cardiovascular risk
por: Kearney, Katherine, et al.
Publicado: (2017) -
Nitric oxide resistance at the platelet level: pathophysiology and therapeutic implications
por: Horowitz, John, et al.
Publicado: (2009)